nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—MPO—prostate cancer	0.631	1	CbGaD
Cefaclor—MPO—IL23-mediated signaling events—IL24—prostate cancer	0.00234	0.0479	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—ZFHX3—prostate cancer	0.00211	0.0433	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—SERPINA3—prostate cancer	0.00203	0.0415	CbGpPWpGaD
Cefaclor—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A1—prostate cancer	0.00166	0.0339	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—SERPINA3—prostate cancer	0.00165	0.0338	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—RFK—prostate cancer	0.00155	0.0318	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—SEPP1—prostate cancer	0.00154	0.0316	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—VIMP—prostate cancer	0.00154	0.0316	CbGpPWpGaD
Cefaclor—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A1—prostate cancer	0.00154	0.0314	CbGpPWpGaD
Cefaclor—SLC15A1—epithelium—prostate cancer	0.00149	0.116	CbGeAlD
Cefaclor—MPO—Selenium Micronutrient Network—TXNRD2—prostate cancer	0.00141	0.0289	CbGpPWpGaD
Cefaclor—SLC15A1—renal system—prostate cancer	0.00138	0.108	CbGeAlD
Cefaclor—MPO—epithelium—prostate cancer	0.00134	0.105	CbGeAlD
Cefaclor—MPO—Selenium Micronutrient Network—SERPINA3—prostate cancer	0.00131	0.0269	CbGpPWpGaD
Cefaclor—SLC15A2—prostate gland—prostate cancer	0.00127	0.0991	CbGeAlD
Cefaclor—MPO—renal system—prostate cancer	0.00124	0.0972	CbGeAlD
Cefaclor—MPO—Selenium Micronutrient Network—RFK—prostate cancer	0.00123	0.0252	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—TCN2—prostate cancer	0.00117	0.0239	CbGpPWpGaD
Cefaclor—SLC15A2—seminal vesicle—prostate cancer	0.00107	0.0838	CbGeAlD
Cefaclor—MPO—Selenium Micronutrient Network—PRDX2—prostate cancer	0.000994	0.0204	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.000974	0.0199	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—LRP2—prostate cancer	0.000951	0.0195	CbGpPWpGaD
Cefaclor—MPO—bone marrow—prostate cancer	0.000939	0.0735	CbGeAlD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.000904	0.0185	CbGpPWpGaD
Cefaclor—SLC15A2—renal system—prostate cancer	0.000863	0.0675	CbGeAlD
Cefaclor—SLC15A2—urethra—prostate cancer	0.000848	0.0663	CbGeAlD
Cefaclor—MPO—testis—prostate cancer	0.000803	0.0628	CbGeAlD
Cefaclor—MPO—C-MYB transcription factor network—CASP6—prostate cancer	0.000697	0.0143	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—GPX3—prostate cancer	0.000686	0.014	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL18—prostate cancer	0.000635	0.013	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.000612	0.0125	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.000612	0.0125	CbGpPWpGaD
Cefaclor—MPO—lymph node—prostate cancer	0.000582	0.0455	CbGeAlD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.000568	0.0116	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.000568	0.0116	CbGpPWpGaD
Cefaclor—SLC15A2—testis—prostate cancer	0.000558	0.0436	CbGeAlD
Cefaclor—MPO—C-MYB transcription factor network—MAD1L1—prostate cancer	0.000557	0.0114	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—GPX3—prostate cancer	0.000545	0.0112	CbGpPWpGaD
Cefaclor—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—prostate cancer	0.000501	0.0103	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—SOD2—prostate cancer	0.000492	0.0101	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—PPP3CA—prostate cancer	0.000481	0.00984	CbGpPWpGaD
Cefaclor—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—prostate cancer	0.000465	0.00952	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000435	0.00891	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—MTHFR—prostate cancer	0.000433	0.00886	CbGpPWpGaD
Cefaclor—SLC15A2—lymph node—prostate cancer	0.000404	0.0316	CbGeAlD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000404	0.00827	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—SOD2—prostate cancer	0.0004	0.00818	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—MAP3K7—prostate cancer	0.000391	0.008	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—GGT1—prostate cancer	0.000383	0.00785	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—JAK2—prostate cancer	0.000379	0.00776	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—ICAM1—prostate cancer	0.000378	0.00774	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—MTHFR—prostate cancer	0.000352	0.00721	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000344	0.00704	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—INS—prostate cancer	0.000344	0.00704	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL2—prostate cancer	0.000331	0.00677	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—GSTM1—prostate cancer	0.000329	0.00672	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000319	0.00654	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—SOD2—prostate cancer	0.000318	0.0065	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—SERPINE1—prostate cancer	0.000316	0.00647	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—ICAM1—prostate cancer	0.000308	0.0063	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000295	0.00604	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—INS—prostate cancer	0.00028	0.00573	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—MTHFR—prostate cancer	0.00028	0.00572	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—STAT3—prostate cancer	0.000278	0.0057	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000274	0.00561	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000273	0.0056	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000273	0.0056	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—SERPINE1—prostate cancer	0.000257	0.00526	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000254	0.00519	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000254	0.00519	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—ICAM1—prostate cancer	0.000245	0.00501	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CREBBP—prostate cancer	0.000226	0.00463	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—INS—prostate cancer	0.000222	0.00455	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000222	0.00454	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000221	0.00453	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—PIK3CA—prostate cancer	0.00022	0.00449	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—IL2—prostate cancer	0.000208	0.00426	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000206	0.00421	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000205	0.0042	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—SERPINE1—prostate cancer	0.000204	0.00418	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—BCL2—prostate cancer	0.000195	0.00399	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL6—prostate cancer	0.000194	0.00398	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—PTGS2—prostate cancer	0.000185	0.00379	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000181	0.0037	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—PTGS2—prostate cancer	0.000178	0.00365	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CDKN1B—prostate cancer	0.000175	0.00359	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000175	0.00358	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000168	0.00343	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CCND1—prostate cancer	0.000167	0.00342	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000162	0.00332	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CDKN1A—prostate cancer	0.000162	0.00331	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—EP300—prostate cancer	0.000154	0.00315	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—IL6—prostate cancer	0.00015	0.00308	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000143	0.00292	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000139	0.00284	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000139	0.00284	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—MYC—prostate cancer	0.000134	0.00275	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—TP53—prostate cancer	0.000134	0.00274	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000132	0.00271	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000132	0.0027	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000129	0.00264	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000129	0.00264	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—KRAS—prostate cancer	0.000124	0.00254	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000122	0.00251	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—IL6—prostate cancer	0.000122	0.0025	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000113	0.00231	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000105	0.00214	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000104	0.00213	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—IL6—prostate cancer	9.72e-05	0.00199	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	9.65e-05	0.00198	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	9.19e-05	0.00188	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	8.74e-05	0.00179	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	8.53e-05	0.00175	CbGpPWpGaD
Cefaclor—Confusional state—Capecitabine—prostate cancer	8.45e-05	0.000275	CcSEcCtD
Cefaclor—Headache—Estradiol—prostate cancer	8.42e-05	0.000274	CcSEcCtD
Cefaclor—Agitation—Prednisone—prostate cancer	8.41e-05	0.000273	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	8.4e-05	0.000273	CcSEcCtD
Cefaclor—Oedema—Capecitabine—prostate cancer	8.38e-05	0.000272	CcSEcCtD
Cefaclor—Angioedema—Prednisone—prostate cancer	8.36e-05	0.000272	CcSEcCtD
Cefaclor—Urticaria—Etoposide—prostate cancer	8.27e-05	0.000269	CcSEcCtD
Cefaclor—Haemoglobin—Epirubicin—prostate cancer	8.26e-05	0.000268	CcSEcCtD
Cefaclor—Anorexia—Docetaxel—prostate cancer	8.25e-05	0.000268	CcSEcCtD
Cefaclor—Malaise—Prednisone—prostate cancer	8.25e-05	0.000268	CcSEcCtD
Cefaclor—Shock—Capecitabine—prostate cancer	8.24e-05	0.000268	CcSEcCtD
Cefaclor—Rhinitis—Epirubicin—prostate cancer	8.24e-05	0.000268	CcSEcCtD
Cefaclor—Body temperature increased—Etoposide—prostate cancer	8.23e-05	0.000268	CcSEcCtD
Cefaclor—Abdominal pain—Etoposide—prostate cancer	8.23e-05	0.000268	CcSEcCtD
Cefaclor—Conjunctivitis—Doxorubicin—prostate cancer	8.23e-05	0.000268	CcSEcCtD
Cefaclor—Nervous system disorder—Capecitabine—prostate cancer	8.22e-05	0.000267	CcSEcCtD
Cefaclor—Vertigo—Prednisone—prostate cancer	8.22e-05	0.000267	CcSEcCtD
Cefaclor—Haemorrhage—Epirubicin—prostate cancer	8.22e-05	0.000267	CcSEcCtD
Cefaclor—Hepatitis—Epirubicin—prostate cancer	8.22e-05	0.000267	CcSEcCtD
Cefaclor—Thrombocytopenia—Capecitabine—prostate cancer	8.2e-05	0.000267	CcSEcCtD
Cefaclor—Syncope—Prednisone—prostate cancer	8.2e-05	0.000267	CcSEcCtD
Cefaclor—Sweating—Doxorubicin—prostate cancer	8.12e-05	0.000264	CcSEcCtD
Cefaclor—Urinary tract disorder—Epirubicin—prostate cancer	8.12e-05	0.000264	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	8.11e-05	0.00166	CbGpPWpGaD
Cefaclor—Hyperhidrosis—Capecitabine—prostate cancer	8.1e-05	0.000263	CcSEcCtD
Cefaclor—Oedema peripheral—Epirubicin—prostate cancer	8.09e-05	0.000263	CcSEcCtD
Cefaclor—Hypotension—Docetaxel—prostate cancer	8.09e-05	0.000263	CcSEcCtD
Cefaclor—Haematuria—Doxorubicin—prostate cancer	8.08e-05	0.000262	CcSEcCtD
Cefaclor—Urethral disorder—Epirubicin—prostate cancer	8.06e-05	0.000262	CcSEcCtD
Cefaclor—Loss of consciousness—Prednisone—prostate cancer	8.04e-05	0.000261	CcSEcCtD
Cefaclor—Hepatobiliary disease—Doxorubicin—prostate cancer	8.01e-05	0.00026	CcSEcCtD
Cefaclor—Epistaxis—Doxorubicin—prostate cancer	7.99e-05	0.00026	CcSEcCtD
Cefaclor—Anorexia—Capecitabine—prostate cancer	7.99e-05	0.00026	CcSEcCtD
Cefaclor—Nausea—Estradiol—prostate cancer	7.98e-05	0.000259	CcSEcCtD
Cefaclor—Vomiting—Mitoxantrone—prostate cancer	7.96e-05	0.000259	CcSEcCtD
Cefaclor—Sinusitis—Doxorubicin—prostate cancer	7.95e-05	0.000258	CcSEcCtD
Cefaclor—Convulsion—Prednisone—prostate cancer	7.92e-05	0.000258	CcSEcCtD
Cefaclor—Agranulocytosis—Doxorubicin—prostate cancer	7.9e-05	0.000257	CcSEcCtD
Cefaclor—Rash—Mitoxantrone—prostate cancer	7.89e-05	0.000257	CcSEcCtD
Cefaclor—Dermatitis—Mitoxantrone—prostate cancer	7.89e-05	0.000256	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.89e-05	0.000256	CcSEcCtD
Cefaclor—Headache—Mitoxantrone—prostate cancer	7.84e-05	0.000255	CcSEcCtD
Cefaclor—Hypotension—Capecitabine—prostate cancer	7.83e-05	0.000254	CcSEcCtD
Cefaclor—Insomnia—Docetaxel—prostate cancer	7.83e-05	0.000254	CcSEcCtD
Cefaclor—Myalgia—Prednisone—prostate cancer	7.79e-05	0.000253	CcSEcCtD
Cefaclor—Arthralgia—Prednisone—prostate cancer	7.79e-05	0.000253	CcSEcCtD
Cefaclor—Paraesthesia—Docetaxel—prostate cancer	7.77e-05	0.000253	CcSEcCtD
Cefaclor—Erythema multiforme—Epirubicin—prostate cancer	7.77e-05	0.000253	CcSEcCtD
Cefaclor—Anxiety—Prednisone—prostate cancer	7.76e-05	0.000252	CcSEcCtD
Cefaclor—Dyspnoea—Docetaxel—prostate cancer	7.72e-05	0.000251	CcSEcCtD
Cefaclor—Somnolence—Docetaxel—prostate cancer	7.69e-05	0.00025	CcSEcCtD
Cefaclor—Discomfort—Prednisone—prostate cancer	7.69e-05	0.00025	CcSEcCtD
Cefaclor—Hypersensitivity—Etoposide—prostate cancer	7.67e-05	0.000249	CcSEcCtD
Cefaclor—Haemoglobin—Doxorubicin—prostate cancer	7.64e-05	0.000248	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.63e-05	0.000248	CcSEcCtD
Cefaclor—Rhinitis—Doxorubicin—prostate cancer	7.62e-05	0.000248	CcSEcCtD
Cefaclor—Dyspepsia—Docetaxel—prostate cancer	7.62e-05	0.000248	CcSEcCtD
Cefaclor—Hepatitis—Doxorubicin—prostate cancer	7.6e-05	0.000247	CcSEcCtD
Cefaclor—Haemorrhage—Doxorubicin—prostate cancer	7.6e-05	0.000247	CcSEcCtD
Cefaclor—Insomnia—Capecitabine—prostate cancer	7.58e-05	0.000246	CcSEcCtD
Cefaclor—Paraesthesia—Capecitabine—prostate cancer	7.52e-05	0.000245	CcSEcCtD
Cefaclor—Decreased appetite—Docetaxel—prostate cancer	7.52e-05	0.000245	CcSEcCtD
Cefaclor—Urinary tract disorder—Doxorubicin—prostate cancer	7.51e-05	0.000244	CcSEcCtD
Cefaclor—Oedema peripheral—Doxorubicin—prostate cancer	7.49e-05	0.000243	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Docetaxel—prostate cancer	7.47e-05	0.000243	CcSEcCtD
Cefaclor—Asthenia—Etoposide—prostate cancer	7.47e-05	0.000243	CcSEcCtD
Cefaclor—Dyspnoea—Capecitabine—prostate cancer	7.47e-05	0.000243	CcSEcCtD
Cefaclor—Oedema—Prednisone—prostate cancer	7.46e-05	0.000243	CcSEcCtD
Cefaclor—Anaphylactic shock—Prednisone—prostate cancer	7.46e-05	0.000243	CcSEcCtD
Cefaclor—Urethral disorder—Doxorubicin—prostate cancer	7.45e-05	0.000242	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	7.45e-05	0.00152	CbGpPWpGaD
Cefaclor—Nausea—Mitoxantrone—prostate cancer	7.44e-05	0.000242	CcSEcCtD
Cefaclor—Immune system disorder—Epirubicin—prostate cancer	7.42e-05	0.000241	CcSEcCtD
Cefaclor—Pain—Docetaxel—prostate cancer	7.4e-05	0.000241	CcSEcCtD
Cefaclor—Constipation—Docetaxel—prostate cancer	7.4e-05	0.000241	CcSEcCtD
Cefaclor—Dyspepsia—Capecitabine—prostate cancer	7.38e-05	0.00024	CcSEcCtD
Cefaclor—Chills—Epirubicin—prostate cancer	7.37e-05	0.00024	CcSEcCtD
Cefaclor—Pruritus—Etoposide—prostate cancer	7.37e-05	0.000239	CcSEcCtD
Cefaclor—Shock—Prednisone—prostate cancer	7.34e-05	0.000239	CcSEcCtD
Cefaclor—Nervous system disorder—Prednisone—prostate cancer	7.32e-05	0.000238	CcSEcCtD
Cefaclor—Decreased appetite—Capecitabine—prostate cancer	7.28e-05	0.000237	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Capecitabine—prostate cancer	7.23e-05	0.000235	CcSEcCtD
Cefaclor—Hyperhidrosis—Prednisone—prostate cancer	7.22e-05	0.000235	CcSEcCtD
Cefaclor—Erythema multiforme—Doxorubicin—prostate cancer	7.19e-05	0.000234	CcSEcCtD
Cefaclor—Constipation—Capecitabine—prostate cancer	7.17e-05	0.000233	CcSEcCtD
Cefaclor—Pain—Capecitabine—prostate cancer	7.17e-05	0.000233	CcSEcCtD
Cefaclor—Feeling abnormal—Docetaxel—prostate cancer	7.13e-05	0.000232	CcSEcCtD
Cefaclor—Diarrhoea—Etoposide—prostate cancer	7.13e-05	0.000232	CcSEcCtD
Cefaclor—Anorexia—Prednisone—prostate cancer	7.12e-05	0.000231	CcSEcCtD
Cefaclor—Gastrointestinal pain—Docetaxel—prostate cancer	7.08e-05	0.00023	CcSEcCtD
Cefaclor—Flatulence—Epirubicin—prostate cancer	7.05e-05	0.000229	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	7.03e-05	0.00144	CbGpPWpGaD
Cefaclor—Tension—Epirubicin—prostate cancer	7.02e-05	0.000228	CcSEcCtD
Cefaclor—Nervousness—Epirubicin—prostate cancer	6.95e-05	0.000226	CcSEcCtD
Cefaclor—Back pain—Epirubicin—prostate cancer	6.92e-05	0.000225	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	6.92e-05	0.00142	CbGpPWpGaD
Cefaclor—Feeling abnormal—Capecitabine—prostate cancer	6.91e-05	0.000224	CcSEcCtD
Cefaclor—Dizziness—Etoposide—prostate cancer	6.89e-05	0.000224	CcSEcCtD
Cefaclor—Immune system disorder—Doxorubicin—prostate cancer	6.87e-05	0.000223	CcSEcCtD
Cefaclor—Gastrointestinal pain—Capecitabine—prostate cancer	6.85e-05	0.000223	CcSEcCtD
Cefaclor—Abdominal pain—Docetaxel—prostate cancer	6.84e-05	0.000222	CcSEcCtD
Cefaclor—Body temperature increased—Docetaxel—prostate cancer	6.84e-05	0.000222	CcSEcCtD
Cefaclor—Chills—Doxorubicin—prostate cancer	6.82e-05	0.000222	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Prednisone—prostate cancer	6.8e-05	0.000221	CcSEcCtD
Cefaclor—Insomnia—Prednisone—prostate cancer	6.75e-05	0.000219	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.7e-05	0.00137	CbGpPWpGaD
Cefaclor—Paraesthesia—Prednisone—prostate cancer	6.7e-05	0.000218	CcSEcCtD
Cefaclor—Urticaria—Capecitabine—prostate cancer	6.66e-05	0.000216	CcSEcCtD
Cefaclor—Ill-defined disorder—Epirubicin—prostate cancer	6.64e-05	0.000216	CcSEcCtD
Cefaclor—Abdominal pain—Capecitabine—prostate cancer	6.62e-05	0.000215	CcSEcCtD
Cefaclor—Body temperature increased—Capecitabine—prostate cancer	6.62e-05	0.000215	CcSEcCtD
Cefaclor—Vomiting—Etoposide—prostate cancer	6.62e-05	0.000215	CcSEcCtD
Cefaclor—Agitation—Epirubicin—prostate cancer	6.57e-05	0.000214	CcSEcCtD
Cefaclor—Dyspepsia—Prednisone—prostate cancer	6.57e-05	0.000214	CcSEcCtD
Cefaclor—Rash—Etoposide—prostate cancer	6.57e-05	0.000213	CcSEcCtD
Cefaclor—Dermatitis—Etoposide—prostate cancer	6.56e-05	0.000213	CcSEcCtD
Cefaclor—Headache—Etoposide—prostate cancer	6.52e-05	0.000212	CcSEcCtD
Cefaclor—Flatulence—Doxorubicin—prostate cancer	6.52e-05	0.000212	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	6.52e-05	0.00133	CbGpPWpGaD
Cefaclor—Tension—Doxorubicin—prostate cancer	6.49e-05	0.000211	CcSEcCtD
Cefaclor—Decreased appetite—Prednisone—prostate cancer	6.49e-05	0.000211	CcSEcCtD
Cefaclor—Malaise—Epirubicin—prostate cancer	6.45e-05	0.00021	CcSEcCtD
Cefaclor—Nervousness—Doxorubicin—prostate cancer	6.43e-05	0.000209	CcSEcCtD
Cefaclor—Vertigo—Epirubicin—prostate cancer	6.43e-05	0.000209	CcSEcCtD
Cefaclor—Syncope—Epirubicin—prostate cancer	6.41e-05	0.000208	CcSEcCtD
Cefaclor—Leukopenia—Epirubicin—prostate cancer	6.4e-05	0.000208	CcSEcCtD
Cefaclor—Back pain—Doxorubicin—prostate cancer	6.4e-05	0.000208	CcSEcCtD
Cefaclor—Constipation—Prednisone—prostate cancer	6.38e-05	0.000207	CcSEcCtD
Cefaclor—Hypersensitivity—Docetaxel—prostate cancer	6.38e-05	0.000207	CcSEcCtD
Cefaclor—Palpitations—Epirubicin—prostate cancer	6.32e-05	0.000205	CcSEcCtD
Cefaclor—Loss of consciousness—Epirubicin—prostate cancer	6.29e-05	0.000204	CcSEcCtD
Cefaclor—Cough—Epirubicin—prostate cancer	6.24e-05	0.000203	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.22e-05	0.00127	CbGpPWpGaD
Cefaclor—Asthenia—Docetaxel—prostate cancer	6.21e-05	0.000202	CcSEcCtD
Cefaclor—Convulsion—Epirubicin—prostate cancer	6.2e-05	0.000201	CcSEcCtD
Cefaclor—Nausea—Etoposide—prostate cancer	6.19e-05	0.000201	CcSEcCtD
Cefaclor—Hypersensitivity—Capecitabine—prostate cancer	6.17e-05	0.000201	CcSEcCtD
Cefaclor—Feeling abnormal—Prednisone—prostate cancer	6.15e-05	0.0002	CcSEcCtD
Cefaclor—Ill-defined disorder—Doxorubicin—prostate cancer	6.14e-05	0.0002	CcSEcCtD
Cefaclor—Pruritus—Docetaxel—prostate cancer	6.12e-05	0.000199	CcSEcCtD
Cefaclor—Gastrointestinal pain—Prednisone—prostate cancer	6.1e-05	0.000198	CcSEcCtD
Cefaclor—Chest pain—Epirubicin—prostate cancer	6.09e-05	0.000198	CcSEcCtD
Cefaclor—Arthralgia—Epirubicin—prostate cancer	6.09e-05	0.000198	CcSEcCtD
Cefaclor—Myalgia—Epirubicin—prostate cancer	6.09e-05	0.000198	CcSEcCtD
Cefaclor—Agitation—Doxorubicin—prostate cancer	6.08e-05	0.000198	CcSEcCtD
Cefaclor—Anxiety—Epirubicin—prostate cancer	6.07e-05	0.000197	CcSEcCtD
Cefaclor—Discomfort—Epirubicin—prostate cancer	6.02e-05	0.000196	CcSEcCtD
Cefaclor—Asthenia—Capecitabine—prostate cancer	6.01e-05	0.000195	CcSEcCtD
Cefaclor—Malaise—Doxorubicin—prostate cancer	5.97e-05	0.000194	CcSEcCtD
Cefaclor—Vertigo—Doxorubicin—prostate cancer	5.95e-05	0.000193	CcSEcCtD
Cefaclor—Syncope—Doxorubicin—prostate cancer	5.94e-05	0.000193	CcSEcCtD
Cefaclor—Urticaria—Prednisone—prostate cancer	5.93e-05	0.000193	CcSEcCtD
Cefaclor—Pruritus—Capecitabine—prostate cancer	5.93e-05	0.000193	CcSEcCtD
Cefaclor—Leukopenia—Doxorubicin—prostate cancer	5.92e-05	0.000193	CcSEcCtD
Cefaclor—Diarrhoea—Docetaxel—prostate cancer	5.92e-05	0.000192	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.92e-05	0.00121	CbGpPWpGaD
Cefaclor—Abdominal pain—Prednisone—prostate cancer	5.9e-05	0.000192	CcSEcCtD
Cefaclor—Body temperature increased—Prednisone—prostate cancer	5.9e-05	0.000192	CcSEcCtD
Cefaclor—Confusional state—Epirubicin—prostate cancer	5.89e-05	0.000191	CcSEcCtD
Cefaclor—Palpitations—Doxorubicin—prostate cancer	5.85e-05	0.00019	CcSEcCtD
Cefaclor—Oedema—Epirubicin—prostate cancer	5.84e-05	0.00019	CcSEcCtD
Cefaclor—Anaphylactic shock—Epirubicin—prostate cancer	5.84e-05	0.00019	CcSEcCtD
Cefaclor—Loss of consciousness—Doxorubicin—prostate cancer	5.82e-05	0.000189	CcSEcCtD
Cefaclor—Cefdinir—MPO—prostate cancer	5.81e-05	0.461	CrCbGaD
Cefaclor—Cough—Doxorubicin—prostate cancer	5.78e-05	0.000188	CcSEcCtD
Cefaclor—Shock—Epirubicin—prostate cancer	5.74e-05	0.000187	CcSEcCtD
Cefaclor—Convulsion—Doxorubicin—prostate cancer	5.73e-05	0.000186	CcSEcCtD
Cefaclor—Diarrhoea—Capecitabine—prostate cancer	5.73e-05	0.000186	CcSEcCtD
Cefaclor—Nervous system disorder—Epirubicin—prostate cancer	5.73e-05	0.000186	CcSEcCtD
Cefaclor—Dizziness—Docetaxel—prostate cancer	5.72e-05	0.000186	CcSEcCtD
Cefaclor—Thrombocytopenia—Epirubicin—prostate cancer	5.72e-05	0.000186	CcSEcCtD
Cefaclor—Hyperhidrosis—Epirubicin—prostate cancer	5.64e-05	0.000183	CcSEcCtD
Cefaclor—Chest pain—Doxorubicin—prostate cancer	5.63e-05	0.000183	CcSEcCtD
Cefaclor—Myalgia—Doxorubicin—prostate cancer	5.63e-05	0.000183	CcSEcCtD
Cefaclor—Arthralgia—Doxorubicin—prostate cancer	5.63e-05	0.000183	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	5.63e-05	0.00115	CbGpPWpGaD
Cefaclor—Anxiety—Doxorubicin—prostate cancer	5.62e-05	0.000182	CcSEcCtD
Cefaclor—Discomfort—Doxorubicin—prostate cancer	5.57e-05	0.000181	CcSEcCtD
Cefaclor—Anorexia—Epirubicin—prostate cancer	5.56e-05	0.000181	CcSEcCtD
Cefaclor—Dizziness—Capecitabine—prostate cancer	5.54e-05	0.00018	CcSEcCtD
Cefaclor—Vomiting—Docetaxel—prostate cancer	5.5e-05	0.000179	CcSEcCtD
Cefaclor—Hypersensitivity—Prednisone—prostate cancer	5.5e-05	0.000179	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.5e-05	0.00112	CbGpPWpGaD
Cefaclor—Rash—Docetaxel—prostate cancer	5.46e-05	0.000177	CcSEcCtD
Cefaclor—Hypotension—Epirubicin—prostate cancer	5.46e-05	0.000177	CcSEcCtD
Cefaclor—Dermatitis—Docetaxel—prostate cancer	5.45e-05	0.000177	CcSEcCtD
Cefaclor—Confusional state—Doxorubicin—prostate cancer	5.45e-05	0.000177	CcSEcCtD
Cefaclor—Headache—Docetaxel—prostate cancer	5.42e-05	0.000176	CcSEcCtD
Cefaclor—Anaphylactic shock—Doxorubicin—prostate cancer	5.4e-05	0.000176	CcSEcCtD
Cefaclor—Oedema—Doxorubicin—prostate cancer	5.4e-05	0.000176	CcSEcCtD
Cefaclor—Asthenia—Prednisone—prostate cancer	5.36e-05	0.000174	CcSEcCtD
Cefaclor—Vomiting—Capecitabine—prostate cancer	5.33e-05	0.000173	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.32e-05	0.000173	CcSEcCtD
Cefaclor—Shock—Doxorubicin—prostate cancer	5.31e-05	0.000173	CcSEcCtD
Cefaclor—Nervous system disorder—Doxorubicin—prostate cancer	5.3e-05	0.000172	CcSEcCtD
Cefaclor—Thrombocytopenia—Doxorubicin—prostate cancer	5.29e-05	0.000172	CcSEcCtD
Cefaclor—Rash—Capecitabine—prostate cancer	5.28e-05	0.000172	CcSEcCtD
Cefaclor—Pruritus—Prednisone—prostate cancer	5.28e-05	0.000172	CcSEcCtD
Cefaclor—Insomnia—Epirubicin—prostate cancer	5.28e-05	0.000172	CcSEcCtD
Cefaclor—Dermatitis—Capecitabine—prostate cancer	5.28e-05	0.000172	CcSEcCtD
Cefaclor—Headache—Capecitabine—prostate cancer	5.25e-05	0.000171	CcSEcCtD
Cefaclor—Paraesthesia—Epirubicin—prostate cancer	5.24e-05	0.00017	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	5.23e-05	0.00107	CbGpPWpGaD
Cefaclor—Hyperhidrosis—Doxorubicin—prostate cancer	5.22e-05	0.00017	CcSEcCtD
Cefaclor—Dyspnoea—Epirubicin—prostate cancer	5.2e-05	0.000169	CcSEcCtD
Cefaclor—Somnolence—Epirubicin—prostate cancer	5.19e-05	0.000169	CcSEcCtD
Cefaclor—Anorexia—Doxorubicin—prostate cancer	5.15e-05	0.000167	CcSEcCtD
Cefaclor—Nausea—Docetaxel—prostate cancer	5.14e-05	0.000167	CcSEcCtD
Cefaclor—Dyspepsia—Epirubicin—prostate cancer	5.14e-05	0.000167	CcSEcCtD
Cefaclor—Diarrhoea—Prednisone—prostate cancer	5.11e-05	0.000166	CcSEcCtD
Cefaclor—Decreased appetite—Epirubicin—prostate cancer	5.07e-05	0.000165	CcSEcCtD
Cefaclor—Hypotension—Doxorubicin—prostate cancer	5.05e-05	0.000164	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Epirubicin—prostate cancer	5.04e-05	0.000164	CcSEcCtD
Cefaclor—Constipation—Epirubicin—prostate cancer	4.99e-05	0.000162	CcSEcCtD
Cefaclor—Pain—Epirubicin—prostate cancer	4.99e-05	0.000162	CcSEcCtD
Cefaclor—Nausea—Capecitabine—prostate cancer	4.98e-05	0.000162	CcSEcCtD
Cefaclor—Dizziness—Prednisone—prostate cancer	4.94e-05	0.00016	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.92e-05	0.00016	CcSEcCtD
Cefaclor—Insomnia—Doxorubicin—prostate cancer	4.89e-05	0.000159	CcSEcCtD
Cefaclor—Paraesthesia—Doxorubicin—prostate cancer	4.85e-05	0.000158	CcSEcCtD
Cefaclor—Dyspnoea—Doxorubicin—prostate cancer	4.82e-05	0.000157	CcSEcCtD
Cefaclor—Feeling abnormal—Epirubicin—prostate cancer	4.81e-05	0.000156	CcSEcCtD
Cefaclor—Somnolence—Doxorubicin—prostate cancer	4.8e-05	0.000156	CcSEcCtD
Cefaclor—Gastrointestinal pain—Epirubicin—prostate cancer	4.77e-05	0.000155	CcSEcCtD
Cefaclor—Dyspepsia—Doxorubicin—prostate cancer	4.75e-05	0.000155	CcSEcCtD
Cefaclor—Vomiting—Prednisone—prostate cancer	4.75e-05	0.000154	CcSEcCtD
Cefaclor—Rash—Prednisone—prostate cancer	4.71e-05	0.000153	CcSEcCtD
Cefaclor—Dermatitis—Prednisone—prostate cancer	4.7e-05	0.000153	CcSEcCtD
Cefaclor—Decreased appetite—Doxorubicin—prostate cancer	4.7e-05	0.000153	CcSEcCtD
Cefaclor—Headache—Prednisone—prostate cancer	4.68e-05	0.000152	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.66e-05	0.000152	CcSEcCtD
Cefaclor—Urticaria—Epirubicin—prostate cancer	4.64e-05	0.000151	CcSEcCtD
Cefaclor—Pain—Doxorubicin—prostate cancer	4.62e-05	0.00015	CcSEcCtD
Cefaclor—Constipation—Doxorubicin—prostate cancer	4.62e-05	0.00015	CcSEcCtD
Cefaclor—Body temperature increased—Epirubicin—prostate cancer	4.62e-05	0.00015	CcSEcCtD
Cefaclor—Abdominal pain—Epirubicin—prostate cancer	4.62e-05	0.00015	CcSEcCtD
Cefaclor—Feeling abnormal—Doxorubicin—prostate cancer	4.45e-05	0.000145	CcSEcCtD
Cefaclor—Nausea—Prednisone—prostate cancer	4.43e-05	0.000144	CcSEcCtD
Cefaclor—Gastrointestinal pain—Doxorubicin—prostate cancer	4.42e-05	0.000144	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	4.3e-05	0.00088	CbGpPWpGaD
Cefaclor—Hypersensitivity—Epirubicin—prostate cancer	4.3e-05	0.00014	CcSEcCtD
Cefaclor—Urticaria—Doxorubicin—prostate cancer	4.29e-05	0.000139	CcSEcCtD
Cefaclor—Abdominal pain—Doxorubicin—prostate cancer	4.27e-05	0.000139	CcSEcCtD
Cefaclor—Body temperature increased—Doxorubicin—prostate cancer	4.27e-05	0.000139	CcSEcCtD
Cefaclor—Asthenia—Epirubicin—prostate cancer	4.19e-05	0.000136	CcSEcCtD
Cefaclor—Pruritus—Epirubicin—prostate cancer	4.13e-05	0.000134	CcSEcCtD
Cefaclor—Diarrhoea—Epirubicin—prostate cancer	3.99e-05	0.00013	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.99e-05	0.000817	CbGpPWpGaD
Cefaclor—Hypersensitivity—Doxorubicin—prostate cancer	3.98e-05	0.000129	CcSEcCtD
Cefaclor—Asthenia—Doxorubicin—prostate cancer	3.88e-05	0.000126	CcSEcCtD
Cefaclor—Dizziness—Epirubicin—prostate cancer	3.86e-05	0.000125	CcSEcCtD
Cefaclor—Pruritus—Doxorubicin—prostate cancer	3.82e-05	0.000124	CcSEcCtD
Cefaclor—Vomiting—Epirubicin—prostate cancer	3.71e-05	0.000121	CcSEcCtD
Cefaclor—Diarrhoea—Doxorubicin—prostate cancer	3.7e-05	0.00012	CcSEcCtD
Cefaclor—Rash—Epirubicin—prostate cancer	3.68e-05	0.00012	CcSEcCtD
Cefaclor—Dermatitis—Epirubicin—prostate cancer	3.68e-05	0.00012	CcSEcCtD
Cefaclor—Headache—Epirubicin—prostate cancer	3.66e-05	0.000119	CcSEcCtD
Cefaclor—Dizziness—Doxorubicin—prostate cancer	3.57e-05	0.000116	CcSEcCtD
Cefaclor—Nausea—Epirubicin—prostate cancer	3.47e-05	0.000113	CcSEcCtD
Cefaclor—Vomiting—Doxorubicin—prostate cancer	3.43e-05	0.000112	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.42e-05	0.000699	CbGpPWpGaD
Cefaclor—Rash—Doxorubicin—prostate cancer	3.41e-05	0.000111	CcSEcCtD
Cefaclor—Dermatitis—Doxorubicin—prostate cancer	3.4e-05	0.000111	CcSEcCtD
Cefaclor—Headache—Doxorubicin—prostate cancer	3.38e-05	0.00011	CcSEcCtD
Cefaclor—Amoxicillin—CYP2C19—prostate cancer	3.32e-05	0.263	CrCbGaD
Cefaclor—Nausea—Doxorubicin—prostate cancer	3.21e-05	0.000104	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.17e-05	0.000649	CbGpPWpGaD
Cefaclor—Cefradine—CYP3A4—prostate cancer	2.11e-05	0.168	CrCbGaD
Cefaclor—Cephalexin—CYP3A4—prostate cancer	1.37e-05	0.108	CrCbGaD
